Skip to main content
. Author manuscript; available in PMC: 2024 Jul 11.
Published in final edited form as: Immunity. 2023 May 25;56(7):1649–1663.e5. doi: 10.1016/j.immuni.2023.04.019

Figure 4. AlloHSCT mediates profound decreases in intact SIV proviruses.

Figure 4.

Longitudinal intact SIV provirus copies in CD4+ T cells from blood and LN of alloHSCT recipients (colored symbols) and time-matched no-transplant controls (black symbols) from Figure 1. Measurements shown are corrected for double positive 2-LTR circles. Undetectable values are graphed at 0. Colored dotted vertical lines indicate the day of HSCT for each recipient macaque. Gray bars above each graph denote ART treatment. See also figure S4.